Correction to: Biopsychosoc Med (2020) 14:14
https://doi.org/10.1186/s13030-020-00186-8
Anzeige
Following publication of the original article [1], the authors identified an error in Table 1, Table 2 and Table 3. The dagger mark (
♱) in the Tables 1, 2, 3 disappears in the pdf version due to typesetting error. The HTML version is correct.
Table 1
Demographic data at admission and after 3 months of treatment
AN-R (n = 38) | AN-BP (n = 31) | Control group | |||
|---|---|---|---|---|---|
on admission | after 3 months | on admission | after 3 months | (n = 25) | |
Age (years) | 28.42 ± 12.39 | 28.42 ± 12.39 | 32.43 ± 8.19 | 32.30 ± 8.19 | 29.33 ± 6.55 |
Duration of anorexia (days) | 2114.08 ± 3255.41 | NR | 2629.29 ± 2037.48 | NR | NR |
Height (cm) | 154.44 ± 5.39∗ | 154.77 ± 5.85∗ | 158.27 ± 3.59 | 158.47 ± 3.71 | 160.16 ± 3.02 |
Body weight (kg) | 30.73 ± 5.50∗ | 37.86 ± 6.04∗ † | 30.33 ± 3.76∗ | 38.12 ± 5.03∗ † | 51.99 ± 4.79 |
Body mass index (kg/m2) | 12.81 ± 2.00∗ | 15.77 ± 2.15∗ † | 12.17 ± 1.58∗ | 15.25 ± 2.00∗ † | 20.20 ± 1.91 |
Fat mass (g) | 3498.3 ± 1611.31 | 8272.79 ± 3604.42 † | 4054.34 ± 1572.67 | 9557.05 ± 5310.85 † | NR |
Lean body mass (g) | 27,283.02 ± 3242.18 | 30,321.15 ± 3556.30 † | 26,914.63 ± 2493.5 | 26,616.08 ± 2334.50 † | NR |
Percentage of fat mass (%) | 10.62 ± 3.81 | 20.04 ± 7.09 † | 12.07 ± 3.70 | 20.42 ± 3.77 † | NR |
Table 2
Biochemical parameters on admission and after 3 months of treatment
AN-R (n = 38) | AN-BP (n = 31) | Control group | |||
|---|---|---|---|---|---|
on admission | after 3 months | on admission | after 3 months | (n = 25) | |
Glucose (mg/l) | 79.79 ± 16.93 | 80.32 ± 7.73 | 76.7 ± 12.09∗ | 81.42 ± 7.42 † | 85.40 ± 8.95 |
Total cholesterol (mg/dl) | 189.32 ± 60.08 | 193 ± 37.17 | 228.83 ± 50.95∗ | 208.68 ± 42.71 | 200.16 ± 28.46 |
Triacylglycerol (mg/dl) | 74.24 ± 37.28 | 73.55 ± 23.06 | 108.73 ± 47.99∗ | 83.26 ± 44.51 | 58.54 ± 19.45 |
HDL-C (mg/dl) | 70.47 ± 19.63 | 69.91 ± 17.46 | 74.2 ± 25.32 | 70.79 ± 15.66 | 74.24 ± 16.42 |
TSH (μU/ml) | 2.61 ± 2.27 | 2.31 ± 1.29 | 1.629 ± 1.16 | 1.79 ± 0.65 | 2.01 ± 0.72 |
FT3 (pg/ml) | 1.93 ± 0.60∗ | 2.71 ± 0.69∗ † | 2.06 ± 0.53∗ | 2.35 ± 0.32∗ † | 3.21 ± 0.40 |
FT4 (ng/dl) | 1.07 ± 0.24∗ | 0.92 ± 0.18∗ † | 1.16 ± 0.33 | 0.92 ± 0.18∗ † | 1.29 ± 0.20 |
Cortisol (μg/dl) | 20.19 ± 6.56∗ | 12.79 ± 4.11 † | 20.33 ± 6.47∗ | 13.26 ± 4.09 † | 15.68 ± 3.70 |
GH (nU/ml) | 12.30 ± 19.84∗ | 3.01 ± 6.78 † | 8.65 ± 14.00 | 2.52 ± 1.94 † | 2.50 ± 2.67 |
AST (IU/l) | 43.82 ± 48.32 | 34.81 ± 23.30 | 72.48 ± 203.63 | 34.83 ± 27.36 | NR |
ALT (IU/l) | 50.34 ± 40.26 | 47.36 ± 39.67 | 53.00 ± 99.29 | 42.17 ± 26.80 | NR |
Table 3
Fatty acid composition on admission and after 3 months of treatment
AN-R (n=38) | AN-BP (n=31) | Control group | |||
|---|---|---|---|---|---|
on admission | after 3 months | on admission | after 3 months | (n = 25) | |
C12:0 (μg/ml) | 2.62 ± 1.98 | 3.10 ± 1.41 | 3.82 ± 3.17 | 3.84 ± 3.19 | 3.66 ± 4.16 |
C14:0 (μg/ml) | 16.12 ± 5.59 | 25.58 ± 7.04∗ † | 21.78 ± 8.85∗ | 29.89 ± 13.75∗ | 15.48 ± 6.20 |
C14:1n-5 (μg/ml) | 1.42 ± 0.71 | 2.15 ± 0.87∗ † | 2.27 ± 1.27∗ | 3.01 ± 1.58∗ | 1.29 ± 0.65 |
C16:0 (μg/ml) | 488.11 ± 162.94 | 493.89 ± 93.78 | 603.93 ± 156.37∗ | 537.83 ± 130.01 | 457.96 ± 70.72 |
C16:1n-7 (μg/ml) | 42.55 ± 23.35 | 46.47 ± 19.09 | 83.35 ± 44.26∗ | 55.39 ± 35.42 † | 35.64 ± 11.76 |
C18:0 (μg/ml) | 231.11 ± 49.62 | 243.47 ± 39.59 | 274.06 ± 63.23∗ | 263.44 ± 41.13 | 232.80 ± 39.22 |
C18:1n-9 (μg/ml) | 523.11 ± 253.63 | 406.00 ± 68.07 | 721.10 ± 209.79∗ | 458.22 ± 126.84 † | 461.12 ± 100.02 |
C18:2n-6 (μg/ml) | 794.34 ± 217.25 | 736.31 ± 170.57 | 973.61 ± 286.45∗ | 851.22 ± 173.29 | 820.48 ± 160.14 |
C18:3n-6 (μg/ml) | 5.71 ± 4.90 | 8.71 ± 5.44 | 8.40 ± 5.67 | 9.94 ± 5.17∗ | 6.11 ± 3.32 |
C18:3n-3 (μg/ml) | 20.48 ± 8.39∗ | 22.95 ± 7.01∗ | 24.86 ± 8.53∗ | 25.78 ± 10.44∗ | 15.72 ± 5.57 |
C20:0 (μg/ml) | 2.04 ± 0.57∗ | 1.83 ± 0.41 | 2.15 ± 0.66∗ | 1.82 ± 0.39 | 1.56 ± 0.29 |
C20:1n-9 (μg/ml) | 6.07 ± 2.40∗ | 5.54 ± 2.64 | 5.89 ± 2.19∗ | 6.57 ± 3.5∗ | 4.26 ± 0.86 |
C20:2n-6 (μg/ml) | 5.71 ± 3.25 | 5.83 ± 1.39∗ | 6.87 ± 3.78∗ | 7.26 ± 2.01∗ | 4.69 ± 1.26 |
C20:3n-9 (μg/ml) | 1.29 ± 1.45 | 1.15 ± 0.30 | 1.50 ± 0.68 | 1.54 ± 0.86 | 1.36 ± 0.37 |
C20:3n-6 (μg/ml) | 21.36 ± 10.65 | 29.78 ± 10.06 † | 29.06 ± 17.47 | 37.00 ± 16.44∗ † | 24.06 ± 8.59 |
C20:4n-6 (μg/ml) | 163.21 ± 62.70 | 132.47 ± 40.96∗ | 175.06 ± 61.08 | 151.33 ± 42.28 | 183.84 ± 47.08 |
C20:5n-3 (μg/ml) | 60.09 ± 44.89∗ | 86.89 ± 30.13∗ † | 40.98 ± 28.97 | 75.94 ± 30.24∗ † | 36.08 ± 22.78 |
C22:0 (μg/ml) | 1.54 ± 0.77∗ | 1.66 ± 1.06∗ | 1.46 ± 0.86∗ | 1.75 ± 0.97∗ | 0.90 ± 0.42 |
C22:1n-9 (μg/ml) | 2.63 ± 0.98∗ | 2.62 ± 2.20 | 2.72 ± 1.21∗ | 2.99 ± 2.23 | 1.76 ± 0.65 |
C22:5n-3 (μg/ml) | 17.82 ± 6.60 | 25.37 ± 6.26∗ † | 19.06 ± 5.95∗ | 25.44 ± 8.23∗ † | 15.73 ± 3.24 |
C22:6n-3 (μg/ml) | 98.26 ± 44.55 | 114.63 ± 44.99 † | 96.71 ± 41.14 | 100.11 ± 38.07 | 84.92 ± 27.89 |
C24:0 (μg/ml) | 1.46 ± 0.56∗ | 1.42 ± 0.57∗ | 1.62 ± 0.65∗ | 1.58 ± 8.25∗ | 0.96 ± 0.28 |
C24:1n-9 (μg/ml) | 2.41 ± 1.58 | 1.90 ± 1.32 | 2.42 ± 1.59 | 2.33 ± 8.26 | 1.60 ± 0.47 |
C22:4n-6 (μg/ml) | 3.86 ± 2.07 | 3.42 ± 1.19 | 4.71 ± 1.71∗ | 4.33 ± 2.07 | 3.72 ± 0.92 |
Total (μg/ml) | 2515.84 ± 703.48 | 2401.55 ± 347.34 | 3096.36 ± 716.48∗ | 2658.56 ± 8.27 | 2417.48 ± 363.46 |
The correct tables have been included in this correction, and the original article has been corrected.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.